UK Next-generation Sequencing Market worth $1,587.2 million by 2031
The report "UK Next-generation Sequencing Market by Product (Reagents, Kits, Platforms), Service (CHIP Sequencing, Whole Genome, Methyl, RNA Sequencing), Technology (SBS, Nanopore), Workflow (Sequencing, Data Analysis), Application, Competition - Forecast to 2031", is projected to grow from USD 795.8 million in 2026 to USD 1,587.2 million by 2031, at a CAGR of 14.8% during the forecast period
Browse 60 market data Tables and 18 Figures spread through 250 Pages and in-depth TOC on "UK Next-generation Sequencing Market by Product (Reagents, Kits, Platforms), Service (CHIP Sequencing, Whole Genome, Methyl, RNA Sequencing), Technology (SBS, Nanopore), Workflow (Sequencing, Data Analysis), Application, Competition - Forecast to 2031"
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/uk-next-generation-sequencing-market-209813358.html
Key drivers of growth in the UK next-generation sequencing market include advancements in genomic research capabilities, increased funding for precision medicine initiatives, and strong collaborations between research institutions and technology providers. The UK has demonstrated leadership in pioneering genomic applications such as CRISPR based gene therapy, strengthening its global position in genomic innovation. Government support has further accelerated market development. For instance, the National Health Service (NHS) has invested approximately USD 250 million in genomic services, enhancing the infrastructure for precision medicine and supporting the adoption of advanced sequencing technologies. Next-generation sequencing enables researchers and clinicians to perform high precision genomic analysis, identify genetic variations, and improve transparency across research and clinical workflows. Access to advanced sequencing platforms, bioinformatics tools, and digital infrastructure, particularly in urban research hubs, supports efficient genomic data analysis and the use of artificial intelligence to interpret complex genomic datasets.
The single molecule real-time sequencing segment is expected to account for significant growth in the UK next-generation sequencing market during the forecast period.
By technology, the UK next-generation sequencing market is segmented into sequencing by synthesis, ion semiconductor sequencing, single molecule real-time sequencing, nanopore sequencing, and other sequencing technologies. Single molecule real-time sequencing is expected to capture substantial market growth during the forecast period, with a projected CAGR of 9.6%. This is attributed to its long-read capabilities, high accuracy, and ability to detect complex genomic variations. Increasing demand for advanced genomic research, rare disease studies, and precision medicine in the UK is driving its adoption.
The sequencing platforms segment is projected to account for a significant share of the UK next-generation sequencing market in 2025.
By platform, the UK next-generation sequencing market is segmented into sequencing platforms and library preparation platforms. Sequencing platforms segment is expected to account for a share of 79.9% in 2025. They are specialized instruments that enhance the capability and throughput of genomic analysis. Their primary purpose is to enable accurate sequencing of DNA and RNA samples for research and clinical applications.
The UK is expected to register significant growth during the forecast period.
Growing applications in rare disease research, oncology, and precision medicine in the UK are expected to drive the next-generation sequencing market. The country is focusing on developing and adopting advanced sequencing technologies and bioinformatics solutions. Collaborations with technology providers such as Oxford Nanopore Technologies have bolstered regional capabilities in genomic research. The approval of CRISPR-based therapies in the UK highlights regulatory advancements and market readiness for cutting-edge genomic solutions. This growth creates opportunities for institutions to expand their genomic research capabilities and strengthen precision medicine initiatives to meet rising demand during the forecast period.
The report profiles key players such as Illumina, Inc. (US), Thermo Fisher Scientific Inc. (US), Oxford Nanopore Technologies plc. (UK), QIAGEN (Netherlands), Agilent Technologies, Inc. (US), F. Hoffmann-La Roche Ltd. (Switzerland), PacBio (US), and Eurofins Scientific (Luxembourg).
About MarketsandMarkets™
MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.
MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.
Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.
The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.
To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter , LinkedIn and Facebook .
Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit Our Website: https://www.marketsandmarkets.com/
- Triangulate with your Own Data
- Get Data as per your Format and Definition
- Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
- Any level of Personalization
- What are the Known and Unknown Adjacencies Impacting the UK Next-generation Sequencing Market
- What will your New Revenue Sources be?
- Who will be your Top Customer; what will make them switch?
- Defend your Market Share or Win Competitors
- Get a Scorecard for Target Partners
